You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

COVID 19 Vaccine Arcturus

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Covid19, SARS-CoV Infection, Corona Virus Infection Trial in Singapore, United States (ARCT-021 single dose priming, ARCT-021

Terminated
  • Covid19
  • +2 more
  • ARCT-021 single dose priming
  • +5 more
  • Chandler, Arizona
  • +14 more
Jul 7, 2022

COVID-19 Vaccines Trial in Ho Chi Minh City, Ha Noi (ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine, Placebo (normal saline),

Active, not recruiting
  • COVID-19 Vaccines
  • ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine
  • +2 more
  • Ho Chi Minh City, Ho Chi Minh, Vietnam
  • +2 more
Mar 14, 2022

COVID-19, SARS-CoV-2 Infection, Corona Virus Infection Trial in Wichita, Kansas City, Singapore (ARCT-165, ARCT-154, ARCT-021)

Recruiting
  • COVID-19
  • +2 more
  • ARCT-165
  • +2 more
  • Wichita, Kansas
  • +2 more
Nov 10, 2021

COVID-19, Vaccine-Preventable Diseases, SARS CoV 2 Infection Trial (Novavax COVID-19 vaccine (2023-2024 formula XBB containing),

Not yet recruiting
  • COVID-19
  • +4 more
  • Novavax COVID-19 vaccine (2023-2024 formula XBB containing)
  • Pfizer COVID-19 mRNA vaccine (2023-2024 formula XBB containing)
  • (no location specified)
Sep 29, 2023

A Study of the Effectiveness of Moderna COVID-19 Vaccine

Recruiting
  • SARS-CoV-2
  • COVID-19
  • mRNA-1273
  • Pasadena, California
    Kaiser Permanente Southern California
Jul 5, 2023

Vaccine-Preventable Diseases, COVID-19 Pandemic, Health-Related Behavior Trial (Baseline surveys, Digital Storytelling

Not yet recruiting
  • Vaccine-Preventable Diseases
  • +4 more
  • Baseline surveys
  • +2 more
  • (no location specified)
Sep 12, 2023

COVID-19 Disease & Vaccine Survey in Africa

Recruiting
  • COVID-19
  • Vaccine Hesitancy
  • Questionnaire
  • Surrey, British Columbia, Canada
    Salem Anaesthesia Pain Clinic
Jul 18, 2023

SARS-CoV-2 Infection Trial in Hangzhou (Placebo, COVID-19 Vaccine (Vero Cell) ,Inactivated, COVID-19 mRNA Vaccine (ZSVG-02-O) 10

Recruiting
  • SARS-CoV-2 Infection
  • Placebo
  • +4 more
  • Hangzhou, Zhejiang, China
    Shulan (Hangzhou) Hospital
Nov 7, 2023

Sickle Cell Disease, COVID-19 Vaccine, Vaccine Hesitancy Trial in Durham (SCD-specific COVID-19 vaccination information (SCVI)

Not yet recruiting
  • Sickle Cell Disease
  • +2 more
  • SCD-specific COVID-19 vaccination information (SCVI) video
  • Durham, North Carolina
    Duke Adult Sickle Cell Program
Aug 17, 2023

SARS-CoV-2 Infection Trial in Dengfeng, Zhengzhou (COVID-19 mRNA Vaccine (ZSVG-02-O), COVID-19 Vaccine (Vero Cell) ,Inactivated)

Recruiting
  • SARS-CoV-2 Infection
  • COVID-19 mRNA Vaccine (ZSVG-02-O)
  • COVID-19 Vaccine (Vero Cell) ,Inactivated
  • Dengfeng, Henan, China
  • +1 more
Nov 6, 2023

Study of the Effectiveness of The COVID-19 Vaccine

Completed
  • COVID-19
  • COVID-19 Antibody
  • Sukoharjo, Central Java, Indonesia
    Universitas Sebelas Maret Hospital
Mar 9, 2023

COVID-19, Influenza, Vaccine Reaction Trial in Seoul, Incheon (Omicron-containing COVID-19 vaccine, influenza vaccine)

Recruiting
  • COVID-19
  • +3 more
  • Omicron-containing COVID-19 vaccine
  • influenza vaccine
  • Seoul, Guro-gu, Korea, Republic of
  • +1 more
Oct 17, 2023

Covid19, Vaccine Refusal, Vaccine Hesitancy Trial in New Orleans (COVID-19 Vaccine Education at the Point of COVID-19 Testing)

Recruiting
  • Covid19
  • +2 more
  • COVID-19 Vaccine Education at the Point of COVID-19 Testing
  • New Orleans, Louisiana
    Xavier University of Louisiana
Dec 19, 2022

COVID-19 Trial in Manila, Putatan (SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for

Not yet recruiting
  • COVID-19
  • SCB-2023 vaccine (trivalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • SCB-2019 (monovalent), a recombinant SARS-CoV-2 trimeric S-protein subunit vaccine for COVID-19; intramuscular injection
  • Manila, Philippines
  • +2 more
Jun 21, 2023

COVID-19 Trial (GamCovidVac vector vaccine for the prevention of COVID-19 (with altered antigenic profile))

Not yet recruiting
  • COVID-19
  • GamCovidVac vector vaccine for the prevention of COVID-19 (with altered antigenic profile)
  • (no location specified)
Oct 4, 2023

Long-Term Follow-up Survey of COVID-19 Vaccine After Vaccination

Active, not recruiting
  • Coronavirus Disease (COVID-19)
  • COVID-19 Vaccine
  • Tokyo, Japan
    Moderna selected site
Jan 12, 2023

COVID-19 Trial (Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C), Recombinant COVID-19

Not yet recruiting
  • COVID-19
  • Recombinant COVID-19 Bivalent (XBB+Prototype) Protein Vaccine (Sf9 Cell) (WSK-V101C)
  • Recombinant COVID-19 vaccine(Sf9 Cell) (WSK-V101)
  • (no location specified)
Jun 19, 2023

Vaccination; Infection, COVID-19 Trial (Comirnaty)

Not yet recruiting
  • Vaccination; Infection
  • COVID-19
  • Comirnaty
  • (no location specified)
Aug 4, 2023

COVID-19 Trial (Recombinant variant COVID-19 vaccine(Sf9 cell))

Not yet recruiting
  • COVID-19
  • Recombinant variant COVID-19 vaccine(Sf9 cell)
  • (no location specified)
Mar 10, 2023

COVID-19 Trial (Recombinant variant COVID-19 vaccine (Sf9 cell), Recombinant COVID-19 vaccine (CHO cell), Recombinant COVID-19

Not yet recruiting
  • COVID-19
  • Recombinant variant COVID-19 vaccine (Sf9 cell)
  • +2 more
  • (no location specified)
Mar 10, 2023

COVID-19 Trial (High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell), Low dose of Recombinant

Not yet recruiting
  • COVID-19
  • High dose of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell)
  • +3 more
  • (no location specified)
Jun 19, 2023

Vaccine Hesitancy Trial (Multilevel Intervention)

Not yet recruiting
  • Vaccine Hesitancy
  • Multilevel Intervention
  • (no location specified)
Nov 30, 2023

COVID-19 Trial (GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition)

Not yet recruiting
  • COVID-19
  • GamCovidVac-M vector vaccine for the prevention of COVID-19 with altered antigenic composition
  • (no location specified)
Oct 4, 2023

COVID-19 Vaccines Using Information From California State

Not yet recruiting
  • SARS-CoV-2
  • +2 more
  • Pfizer-BioNTech COVID-19 bivalent mRNA vaccine
  • (no location specified)
May 23, 2023

COVID-19 Pneumonia, Coronavirus Infections Trial in Seha (Recombinant COVID-19 Vaccine (CHO cell,NVSI-06-08), Inactivated

Recruiting
  • COVID-19 Pneumonia
  • Coronavirus Infections
  • Recombinant COVID-19 Vaccine (CHO cell，NVSI-06-08)
  • +2 more
  • Seha, Abu Dhab, United Arab Emirates
    Sheikh Khalifa Medical City
Jan 30, 2023